Clinical Focus


  • Pediatric Hematology-Oncology

Academic Appointments


Professional Education


  • Board Certification: American Board of Pediatrics, Pediatric Hematology-Oncology (2023)
  • Fellowship: Duke University Medical Center Pediatric Hematology-Oncology Fellowship (2023) NC
  • Fellowship: Duke University Medical Center Pediatric Hematology-Oncology Fellowship (2021) NC
  • Board Certification: American Board of Pediatrics, Pediatrics (2018)
  • Residency: Sinai Hospital Of Baltimore (2018) MD
  • Medical Education: University of Northern Texas College of Osteopathic Medicine (2015) TX

Clinical Trials


  • GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG) Recruiting

    The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG). H3K27Mmutant testing will occur as part of standard of care prior to enrollment.

    View full details